Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Karakousis

Showing results (21-30 of 509) with videos related to

Pageof 51
Sort By:
Clinical & Experimental Metastasis|January 28, 2024
Neoadjuvant therapy for resectable melanomaCimarron E Sharon, Giorgos C Karakousis
Annals of Surgical Oncology|September 17, 2025
ASO Author Reflections: Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?Mohammad Saad Farooq, Giorgos C Karakousis
Annals of Surgical Oncology|November 15, 2024
Circulating Micro-RNA as a Predictive Biomarker for Radiation Response in Pancreas CancerMark S Etherington, Giorgos C Karakousis
Annals of Surgical Oncology|February 27, 2021
ASO Author Reflections: Preoperative Biopsy for Retroperitoneal SarcomaRichard J Straker, Giorgos C Karakousis
Annals of Surgical Oncology|July 26, 2022
ASO Author Reflections: Neoadjuvant Treatment for Melanoma-Where Are We Now?Cimarron E Sharon, Giorgos C Karakousis
Clinical & Developmental Immunology|January 15, 2011
Timing of antiretroviral therapy for HIV in the setting of TB treatmentDamani A Piggott, Petros C Karakousis
Journal of Surgical Oncology|February 1, 1985
Surgical intervention of countless metastatic lung lesions: a case reportS Zylstra, C Karakousis, H Takita
PET Clinics|May 10, 2016
Diagnosis of MelanomaGiorgos C Karakousis, Brian J Czerniecki
Annals of Surgical Oncology|July 18, 2022
Educational Review: Neoadjuvant Approaches to MelanomaCimarron E Sharon, Giorgos C Karakousis
The Journal of Infectious Diseases|February 15, 2013
Rv1894c is a novel hypoxia-induced nitronate monooxygenase required for Mycobacterium tuberculosis virulenceLee G Klinkenberg, Petros C Karakousis
Pageof 51

Showing results (21-30 of 509) with videos related to

Sort By:
Pageof 51
Clinical & Experimental Metastasis|January 28, 2024
Neoadjuvant therapy for resectable melanomaCimarron E Sharon, Giorgos C Karakousis
Annals of Surgical Oncology|September 17, 2025
ASO Author Reflections: Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?Mohammad Saad Farooq, Giorgos C Karakousis
Annals of Surgical Oncology|November 15, 2024
Circulating Micro-RNA as a Predictive Biomarker for Radiation Response in Pancreas CancerMark S Etherington, Giorgos C Karakousis
Annals of Surgical Oncology|February 27, 2021
ASO Author Reflections: Preoperative Biopsy for Retroperitoneal SarcomaRichard J Straker, Giorgos C Karakousis
Annals of Surgical Oncology|July 26, 2022
ASO Author Reflections: Neoadjuvant Treatment for Melanoma-Where Are We Now?Cimarron E Sharon, Giorgos C Karakousis
Clinical & Developmental Immunology|January 15, 2011
Timing of antiretroviral therapy for HIV in the setting of TB treatmentDamani A Piggott, Petros C Karakousis
Journal of Surgical Oncology|February 1, 1985
Surgical intervention of countless metastatic lung lesions: a case reportS Zylstra, C Karakousis, H Takita
PET Clinics|May 10, 2016
Diagnosis of MelanomaGiorgos C Karakousis, Brian J Czerniecki
Annals of Surgical Oncology|July 18, 2022
Educational Review: Neoadjuvant Approaches to MelanomaCimarron E Sharon, Giorgos C Karakousis
The Journal of Infectious Diseases|February 15, 2013
Rv1894c is a novel hypoxia-induced nitronate monooxygenase required for Mycobacterium tuberculosis virulenceLee G Klinkenberg, Petros C Karakousis
Pageof 51